Dr. Viscomi is the chief medical officer of GoodCell and a practicing physician, researcher, instructor and entrepreneur. He spent 14 years as a member of Harvard Medical Schools teaching faculty. Recognized as an expert in his field, Salvatore has published and presented nationally and internationally. While on clinical staff at Brigham and Women’s Hospital, he co-founded Brigham NightWatch, one of the ?rst teleradiology networks in the world.
He also served as an executive and board member of FreMon Scienti?c Inc. where he led the development of a next-generation blood product management solution through FDA approval and to market. He now chairs their Professional Advisory Board.
Dr. Viscomi began his path towards medicine while at Columbia University, earning a B.A. in Neuropsychology. Salvatore completed his residency and specialization at Harvard Medical School. He also serves on the mission delivery committee of Make-A-Wish Foundation. In 2016, Dr. Viscomi completed the Executive Education Program at Harvard Business School.
Unlike inherited genetic predispositions, accumulated genetic changes are the result of environmental influences, such as smoking, chemicals or ultra-violet radiation. A growing body of research links somatic changes to an increased likelihood of blood cancers and cardiovascular disease, both heart disease and stroke.